Innovative Eyewear Inc. Net Assets
Innovative Eyewear Inc. net assets. Based on the latest financial reports, Innovative Eyewear Inc. (LUCY) has net assets worth $6.90 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.47 Million) and total liabilities ($574.38K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore LUCY shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.90 Million |
| % of Total Assets | 92.31% |
| Annual Growth Rate | N/A |
| 5-Year Change | 4268.89% |
| 10-Year Change | N/A |
| Growth Volatility | 782.15 |
Net Assets of Innovative Eyewear Inc. (2019–2025)
Net assets of Innovative Eyewear Inc. from 2019 to 2025. This chart illustrates how Innovative Eyewear Inc.'s net assets have evolved over time, based on quarterly financial data. See Innovative Eyewear Inc. balance sheet quality to measure how much of total assets are equity-financed.
Annual Net Assets for Innovative Eyewear Inc. (2019–2025)
The table below shows the annual net assets of Innovative Eyewear Inc. from 2019 to 2025. For live market cap and overall valuation, see Innovative Eyewear Inc. stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $9.07 Million | -0.32% |
| 2024-12-31 | $9.10 Million | +63.62% |
| 2023-12-31 | $5.56 Million | +38.13% |
| 2022-12-31 | $4.02 Million | +1839.33% |
| 2021-12-31 | $207.52K | +138.85% |
| 2020-12-31 | $-534.19K | -10.41% |
| 2019-12-31 | $-483.82K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Innovative Eyewear Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3171565500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Innovative Eyewear Inc. Net Assets Breakdown (December 2025)
Innovative Eyewear Inc. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $55.00 | 0.00% |
| Other Components | $41.39 Million | 456.57% |
| Total Equity | $9.07 Million | 100.00% |
Innovative Eyewear Inc. Competitors by Market Cap
The table below lists competitors of Innovative Eyewear Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Auction Technology Group PLC
LSE:ATG
|
$7.37 Million |
|
Obm Drilchem PT
JK:OBMD
|
$7.37 Million |
|
S&W Corporation
KQ:103230
|
$7.37 Million |
|
Orient Press Limited
NSE:ORIENTLTD
|
$7.38 Million |
|
KIBO ENERGY PLC EO -001
F:1I8
|
$7.36 Million |
|
Jinzhou Port Co Ltd B
SHG:900952
|
$7.35 Million |
|
Hudson Investment Group Ltd
AU:HGL
|
$7.35 Million |
|
Ensysce Biosciences Inc
NASDAQ:ENSC
|
$7.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Innovative Eyewear Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,095,141 to 9,066,139, a change of -29,002 (-0.3%).
- Net loss of 7,591,189 reduced equity.
- New share issuances of 1,229,864 increased equity.
- Other factors increased equity by 6,332,323.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.59 Million | -83.73% |
| Share Issuances | $1.23 Million | +13.57% |
| Other Changes | $6.33 Million | +69.85% |
| Total Change | $- | -0.32% |
Book Value vs Market Value Analysis
This analysis compares Innovative Eyewear Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.37x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-4.87 | $0.84 | x |
| 2020-12-31 | $-3.61 | $0.84 | x |
| 2021-12-31 | $0.79 | $0.84 | x |
| 2022-12-31 | $12.33 | $0.84 | x |
| 2023-12-31 | $10.57 | $0.84 | x |
| 2024-12-31 | $6.08 | $0.84 | x |
| 2025-12-31 | $2.27 | $0.84 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Innovative Eyewear Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -83.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -285.20%
- • Asset Turnover: 0.26x
- • Equity Multiplier: 1.12x
- Recent ROE (-83.73%) is above the historical average (-284.81%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -2269.80% | 0.00x | 0.00x | $-61.04K |
| 2020 | 0.00% | -1347.76% | 0.25x | 0.00x | $-714.76K |
| 2021 | -1563.50% | -469.76% | 0.84x | 3.97x | $-3.27 Million |
| 2022 | -141.18% | -861.16% | 0.14x | 1.17x | $-6.08 Million |
| 2023 | -119.87% | -578.18% | 0.19x | 1.12x | $-7.22 Million |
| 2024 | -85.39% | -474.60% | 0.17x | 1.08x | $-8.68 Million |
| 2025 | -83.73% | -285.20% | 0.26x | 1.12x | $-8.50 Million |
Industry Comparison
This section compares Innovative Eyewear Inc.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $841,624,000
- Average return on equity (ROE) among peers: -88.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Innovative Eyewear Inc. (LUCY) | $6.90 Million | 0.00% | 0.08x | $7.36 Million |
| Akoya Biosciences Inc (AKYA) | $7.59 Million | -728.97% | 15.46x | $64.44 Million |
| Align Technology Inc (ALGN) | $-84.67 Million | 0.00% | 0.00x | $10.86 Billion |
| AngioDynamics Inc (ANGO) | $614.82 Million | 9.98% | 0.36x | $484.83 Million |
| AptarGroup Inc (ATR) | $789.51 Million | 10.09% | 0.60x | $7.66 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $2.21 Billion |
| Avinger Inc (AVGR) | $9.72 Million | -213.00% | 2.03x | $1.52 Million |
| Avantor Inc (AVTR) | $-2.62 Billion | 0.00% | 0.00x | $9.19 Billion |
| Azenta Inc (AZTA) | $310.89 Million | -3.23% | 1.01x | $1.35 Billion |
| Baxter International Inc (BAX) | $6.83 Billion | 32.57% | 1.79x | $13.18 Billion |
| Becton Dickinson and Company (BDX) | $2.49 Billion | 19.29% | 1.03x | $48.93 Billion |
About Innovative Eyewear Inc.
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand… Read more